Indoleamine 2,3-dioxygenase 1 activity, which is reflected in the kynurenine:tryptophan (KT) ratio, therefore modulates systemic and local immune responses [67] and has been used as a marker in systemic inflammatory conditions including inflammatory bowel disease and HIV [68–70]. This evidence concerns the gene IDO1 and inflammatory bowel disease.